Impact of Integrated Upper Limb Spasticity Management Including Botulinum Toxin A on Patient-Centred Goal Attainment: Rationale and Protocol for an International Prospective, Longitudinal Cohort Study (Ulis-Iii)
AuthID
P-00K-KDC
P-00K-KDC